About Annexon
Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.
Leadership at Annexon
The team at the top of the org chart.
Douglas Love
President & Chief Executive Officer
86 reports
Jamie Dananberg
Chief Medical Officer
34 reports
Michael Overdorf
Executive Vice President and Chief Business Officer
21 reports
Dean Richard Artis
EVP And Chief Scientific Officer
15 reports
Jennifer Lew
EVP & Chief Financial Officer
5 reports
Tiffany Cisneros
Sr Executive Assistant
1 report
Ted Yednock
EVP & Chief Innovation Officer
1 report
Violet Torneros
Exec. Director, People Operations
1 report
Rick Artis
Chief Scientific Officer
Board
Beth Stevens
Scientific Advisor
William H. Carson
Board Member
Jung E. Choi
Board Member, Compensation Committee Chair, Science & Technology Committee
Will Waddill
Board Member
Hugh Willison
Scientific Advisor
Bettina M. Cockroft
Board Member
Open Jobs at Annexon (13)
- Annexon · San Francisco Bay Area · 11d$310k – $340k
- Annexon · San Francisco Bay Area · 14d$190k – $224k
- Annexon · San Francisco Bay Area · 14d$400k – $428k
- Annexon · San Francisco Bay Area · 15d$265k – $285k
- Annexon · San Francisco Bay Area · 21d$257k – $286k
- Annexon · San Francisco Bay Area · 21d$194k – $216k
- Annexon · San Francisco Bay Area · 21d$300k – $375k
- Annexon · San Francisco Bay Area · 21d$212k – $228k
- Annexon · San Francisco Bay Area · 2mo$179k – $200k
- Annexon · San Francisco Bay Area · 4mo$354k – $377k
- Annexon · San Francisco Bay Area · 4mo$195k – $217k
- Annexon · San Francisco Bay Area · 4mo$354k – $377k
- Annexon · San Francisco Bay Area · 6mo$336k – $374k